Welcome to our dedicated page for Graham Holdings Co SEC filings (Ticker: GHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Graham Holdings Co's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Graham Holdings Co's regulatory disclosures and financial reporting.
Graham Holdings Company reported that its Kaplan subsidiary has closed the sale of the Kaplan Languages Group. On a preliminary basis, the company expects to record a current U.S. income tax benefit of approximately $60 million in 2026 related to the KLG business.
Graham Holdings Co reports a Schedule 13G showing Vanguard Capital Management beneficially owns 170,911 shares of Common Stock, representing 5.04% of the class as of 03/31/2026.
Vanguard Capital Management discloses sole dispositive power over 170,911 shares and sole voting power over 25,281 shares. The filing states these holdings include securities held for Vanguard funds and managed accounts where Vanguard or its affiliates exercise voting or dispositive power.
Graham Holdings Company reported solid first-quarter 2026 results with broad-based growth. Revenue for the quarter ended March 31, 2026 was $1,235.992 million, up 6% from $1,165.915 million a year earlier, led by education, television broadcasting, healthcare and manufacturing, partly offset by declines in automotive and other businesses.
Operating income rose to $57.833 million from $47.473 million, while net income attributable to common stockholders increased to $29.106 million or $6.62 diluted EPS, from $23.894 million or $5.45. Excluding items such as a $19.029 million impairment related to Kaplan Languages Group, marketable equity securities losses and other adjustments, adjusted net income attributable to common shares was $73.867 million or $16.79 per diluted share, compared with $51.016 million or $11.64 a year earlier.
The company agreed to sell Kaplan Languages Group and classified its assets and liabilities as held for sale, and its healthcare arm acquired Covenant Home Health in Pennsylvania. Graham Holdings ended the quarter with $822.0 million in borrowings at a 5.8% average interest rate and $1,171.8 million in cash, marketable equity securities and other investments. It also repurchased 32,190 Class B shares for $34.1 million, leaving 4,329,530 shares outstanding.
Graham Holdings Company reported first-quarter 2026 net income attributable to common stockholders of $29.1 million, up from $23.9 million a year earlier, with diluted EPS rising to $6.62 from $5.45.
Revenue increased 6% to $1.236 billion, driven by growth in education, television broadcasting, healthcare and manufacturing, partly offset by lower automotive and other businesses revenue. Operating income improved to $57.8 million from $47.5 million, despite a $19.0 million impairment related to Kaplan Languages Group and $4.1 million of separation program costs.
Results also reflected a $68.9 million net loss on marketable equity securities, $31.0 million in net earnings of affiliates, and modest interest income from adjusting a mandatorily redeemable noncontrolling interest. Cash flow from operations strengthened to $67.7 million, while total debt stood at $822.0 million.
Graham Holdings Co reports an institutional ownership disclosure by Vanguard Portfolio Management holding 175,514 shares of Common Stock. The filing states this position represents 5.18% of the class, with 1,577 shares of sole voting power and 175,514 shares of sole dispositive power. The filing is signed by Vanguard's Head of Global Fund Administration on 04/29/2026.
Graham Holdings director G. Richard Wagoner Jr. indirectly acquired 23 shares of Class B Common Stock at $1,061.70 per share through a revocable trust. The shares were received under the Director Share Purchase Program, where the director elected to take board fees in stock instead of cash, bringing the trust’s holdings to 1,533 shares.
Graham Holdings Co director Anne M. Mulcahy, through a revocable trust, acquired 23 shares of Class B Common Stock at $1,061.70 per share. These shares were received as part of her fees for board service under a Director Share Purchase Program instead of cash, bringing the trust’s holdings to 737 shares.
Graham Holdings Co director Jack A. Markell reported a routine stock award under the company’s Director Share Purchase Program. On April 1, 2026, a revocable trust associated with him acquired 8 shares of Class B Common Stock at an indicated value of $1,061.70 per share, in lieu of cash director fees, bringing the trust’s holdings to 41 shares. This was a compensation-related acquisition rather than an open-market purchase.
Graham Holdings Co director Christopher C. Davis acquired 25 shares of Class B Common Stock through a stock-based fee program. The shares were valued at $1,061.70 per share and were received as compensation in stock instead of cash director fees. After this transaction, Davis directly holds 5,591 Class B shares.
Graham Holdings Co director Danielle Y. Conley acquired 21 shares of Class B Common Stock through a compensation election. The shares, valued at $1,061.70 per share, were received in lieu of a portion of her director fees and credited to a revocable trust. Following this award, the trust holds 442 Class B shares indirectly on her behalf. This is a routine, non-market grant under the company’s Director Share Purchase Program rather than an open-market stock purchase.